43
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Effects of personality on the association between paroxetine plasma concentration and response

, , , , , & show all
Pages 3299-3306 | Published online: 29 Nov 2018

References

  • AmsterdamJBrunswickDMendelsJThe clinical application of tricyclic antidepressant pharmacokinetics and plasma levelsAm J Psychiatry198013766536626990798
  • Tricyclic antidepressants – blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in PsychiatryAm J Psychiatry198514221551623881999
  • PerryPJPfohlBMHolstadSGThe relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysisClin Pharmacokinet19871363813923325215
  • PerryPJZeilmannCArndtSTricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of responseJ Clin Psychopharmacol19941442302407962678
  • Yasui-FurukoriNNakagamiTKanedaAInverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disordersHum Psychopharmacol201126860260822102561
  • HiemkeCBaumannPBergemannNAGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011Pharmacopsychiatry2011446195235
  • TomitaTYasui-FurukoriNNakagamiTTherapeutic reference range for plasma concentrations of paroxetine in patients with major depressive disordersTher Drug Monit201436448048525014076
  • TomitaTYasui-FurukoriNNakagamiTThe influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorderPLoS One201495e9809924858363
  • CloningerCRA systematic method for clinical description and classification of personality variants. A proposalArch Gen Psychiatry19874465735883579504
  • CloningerCRSvrakicDMPrzybeckTRA psychobiological model of temperament and characterArch Gen Psychiatry199350129759908250684
  • BrownSLSvrakicDMPrzybeckTRCloningerCRThe relationship of personality to mood and anxiety states: a dimensional approachJ Psychiatr Res19922631972111432846
  • BayonCHillKSvrakicDMPrzybeckTRCloningerCRDimensional assessment of personality in an out-patient sample: relations of the systems of Millon and CloningerJ Psychiatr Res19963053413528923338
  • CloningerCRBayonCSvrakicDMMeasurement of temperament and character in mood disorders: a model of fundamental states as personality typesJ Affect Disord199851121329879800
  • HansenneMReggersJPintoEKjiriKAjamierAAnsseauMTemperament and character inventory (TCI) and depressionJ Psychiatr Res1999331313610094237
  • NaitoMKijimaNKitamuraTTemperament and Character Inventory (TCI) as predictors of depression among Japanese college studentsJ Clin Psychol200056121579158511132572
  • RichterJEisemannMRichterGTemperament and character during the course of unipolar depression among inpatientsEur Arch Psychiatry Clin Neurosci20002501404710738864
  • FarmerAMahmoodARedmanKHarrisTSadlerSMcGuffinPA sib-pair study of the Temperament and Character Inventory scales in major depressionArch Gen Psychiatry200360549049612742870
  • SpittlehouseJKPearsonJFLutySEMeasures of temperament and character are differentially impacted on by depression severityJ Affect Disord20101261–214014620381156
  • KanedaAYasui-FurukoriNNakagamiTSatoYKanekoSThe influence of personality factors on paroxetine response time in patients with major depressionJ Affect Disord20111351–332132521784533
  • PeirsonARHeuchertJWThomalaLBerkMPleinHCloningerCRRelationship between serotonin and the temperament and character inventoryPsychiatry Res1999891293710643875
  • SuharaTYasunoFSudoYDopamine D2 receptors in the insular cortex and the personality trait of novelty seekingNeuroimage200113589189511304084
  • LeeHJLeeHSKimYKD2 and D4 dopamine receptor gene polymorphisms and personality traits in a young Korean populationAm J Med Genet B Neuropsychiatr Genet2003121b1444912898574
  • MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
  • TakahashiNTomitaKHiguchiTInadaTThe inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA)Hum Psychopharmacol200419318719215079853
  • LingjaerdeOAhlforsUGBechPDenckerSJElgenKThe UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patientsActa Psychiatr Scand Suppl198733411002887090
  • KijimaNSaitoRTakeuchiMClininger’s seven-factor model of temperament and character and Japanese version of Temperament and Character Inventory (TCI)Archives of Psychiatric Diagnostics and Clinical Evaluation199673379399
  • Yasui-FurukoriNSaitoMInoueYTerbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjectsEur J Clin Pharmacol2007631515617124578
  • Yasui-FurukoriNSaitoMNiiokaTInoueYSatoYKanekoSEffect of itraconazole on pharmacokinetics of paroxetine: the role of gut transportersTher Drug Monit2007291454817304149
  • JoffeRTReganJJPersonality and response to tricyclic antidepressants in depressed patientsJ Nerv Ment Dis1989177127457492592964
  • JoycePRMulderRTCloningerCRTemperament predicts clomipramine and desipramine response in major depressionJ Affect Disord199430135468151047
  • PeselowEDFieveRRDifigliaCPersonality traits and response to desipramineJ Affect Disord19922442092161578076
  • ReinerISpanglerGDopamine D4 receptor exon III polymorphism, adverse life events and personality traits in a nonclinical German adult sampleNeuropsychobiology2011631525821063133
  • MeyerJHWilsonAASagratiSSerotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C] DASB positron emission tomography studyAm J Psychiatry2004161582683515121647
  • TomitaTKanedaANakagamiTKanekoSYasui-FurukoriNChanges in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorderHum Psychopharmacol201530533434025845342
  • GrayJARothBLParadoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonistsBrain Res Bull200156544145111750789
  • AndreKKampmanOIlliASERT and NET polymorphisms, temperament and antidepressant responseNord J Psychiatry201569753153825739526
  • NishiokaGYashimaHKiuchiYPrediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorderHum Psychopharmacol201328657658524519691
  • MinelliABonviciniCScassellatiCSartoriRGennarelliMThe influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traitsBMC Psychiatry2011115021453464
  • IniestaRHodgsonKStahlDAntidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variablesSci Rep201881553029615645